| HOME >> MEDICINE >> TECHNOLOGY |
Figure 3.1 Breakdown of Pharma Clinical Spending by Phase
Figure 3.2 Pharma Clinical Trial Services Market, 2008-2011
Figure 3.3 Pharma Clinical Trial Services Market by Sector, 2011
Figure 3.4 CRO Clinical Trial Services Revenue by Customer Type, 2011
Figure 3.5 Clinical Trial Services Market: Drivers and Restraints, 2013-2023
Figure 3.6 Pharma Clinical Trial Services Market Forecast, 2011-2023
Figure 3.7 Pharma Clinical Trial Services Market by Sector, 2017
Figure 3.8 Pharma Clinical Trial Services Market by Sector, 2023
Figure 3.9 Early Phase Clinical Trial Services Submarket Forecast, 2011-2023
Figure 3.10 Early Phase Trial Services Submarket: Drivers and Restraints, 2013-2023
Figure 3.11 Late Phase Clinical Trial Services Submarket Forecast, 2011-2023
Figure 3.12 Late Phase Trial Services Submarket: Drivers and Restraints, 2013-2023
Figure 4.1 World Pharma Clinical Trial Services Market by Region, 2011
Figure 4.2 World Pharma Clinical Trial Services Market by Region, 2017
Figure 4.3 World Pharma Clinical Trial Services Market by Region, 2023
Figure 4.4 US Clinical Trial Services Market Forecast, 2011-2023
Figure 4.5 Western European Clinical Trial Services Market by Country, 2011
Figure 4.6 Western European Clinical Trial Services Market Forecast, 2011-2023
Figure 4.7 German Clinical Trial Services Market Forecast, 2011-2023
Figure 4.8 French Clinical Trial Services Market Forecast, 2011-2023
Figure 4.9 UK Clinical Trial Services Market Forecast, 2011-2023
Figure 4.10 Italian Clinical Trial Services Market Forecast, 2011-2023
Figure 4.11 Spanish Clinical Trial Services Market Forecast, 2011-2023
Figure 4.12 Japanese Clinical Trial Services Market Forecast, 2011-2023
Figure 5.1 Leading Emerging Markets for Pharma Clinical Trial Services, 2011
Figure 5.2 Cost Savings Available fo
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |